| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | -0.048 | 0.3 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.3 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.3 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.048 | 0.3 |